MedTrace Logo

Thai MSM/TG Test and Treat Study

NCT01869595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-11-25

No results posted yet for this study

Summary

Objectives

1. To determine the uptake of universal HIV testing among Thai men who have sex with men (MSM) and transgender women (TG)
2. To determine the uptake of antiretroviral treatment (ART) regardless of CD4 count among Thai MSM/TG who test positive for HIV

Subject population:. Men or transgender women who have sex with men,Thai nationals, age ≥18 years old, Have engaged in anal intercourse with a man without using a condom at least one time in the last 6 months or have had at least 3 male sex partners in the last 6 months,Not known to be HIV-positive (either have never been tested for HIV or have had a previous negative HIV test)

Number of participants:2000 Thai MSM and TG with approximately 76%-90% in Bangkok, 5%-12% in Lampang and 5-12% in Ubonratchathani.

Conditions

  • HIV Testing Rate
  • Acceptance of Immediate ART

Sponsors & Collaborators

  • National Research Council of Thailand

    collaborator OTHER_GOV

  • Ministry of Health, Thailand

    collaborator OTHER_GOV

  • The Government Pharmaceutical Organization

    collaborator OTHER_GOV

  • National Health Security Office, Thailand

    collaborator OTHER

  • Thai Red Cross AIDS Research Centre

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2019-12-31
Completion
2020-11-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869595 on ClinicalTrials.gov